Pictet Asset Management Holding Sa Biocryst Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 19,602 shares of BCRX stock, worth $148,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,602
Previous 19,602
-0.0%
Holding current value
$148,583
Previous $99,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
258Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$142 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$95.3 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$70.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$66.9 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.41B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...